Answers are grounded in this paper and cite their sources.
The GOLD guidelines have attempted to provide direction to practitioners by grouping patients into 4 groups based on symptoms and exacerbations however, the low prevalence of GOLD group C may indicate that not all of these groupings are clinically relevant. Future research is needed to better identify clinically relevant phenotypes that predict benefit from ICS and methods to promote guideline concordant management in COPD.
No takes yet. Share an insight, caveat, or question.
Safka et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: